Background:
Medicinal plants and their products are gaining global popularity due to its several health benefits. However, the biological activities of the vast majority of medicinal plant species have not been explored yet. In this
study, we evaluated the enzyme inhibitory potential six medicinal plant species involved in digestion, skin-related problems, and neurological problems.
Methods:
The 80% methanol extract of six locally available plants from the Bagmati province of Nepal were analyzed for
their flavonoids content, phenolics content, antioxidant activity, and enzymes inhibitory potential. Antioxidant activity
was analyzed by the DPPH assay. Alpha-amylase inhibition was carried out by the DNSA method. Lipase, tyrosinase,
elastase, acetylcholinesterase, and butyrylcholinesterase inhibition were analyzed by using p-NPB, L-DOPA, AAAPVN,
acetylthiocholine, and butyrylthiocholine as a respective substrate.
Results:
Among the analyzed plants species, Artocarpus heterophyllus possess highest α-amylase (IC50=6.28±0.01
μg/mL), lipase (IC50=475.14±3.17 μg/mL), elastase (IC50=72.75±3.41 μg/mL) and acetylcholinesterase (IC50= 68.66±1.71
μg/mL) inhibition, whereas, Actinidia deliciosa possess highest tyrosinase inhibition (IC50=139.87±0.72 μg/mL) and butyrylcholinesterase inhibition (IC50=18.32±0.44 μg/mL). Furthermore, Jasminum humile showed no inhibitory tendencies
against elastase and Lygodium japonicum showed no inhibition towards lipase and elastase at given concentration range.
Conclusions:
Our study revealed that A. deliciosa and A. heterophyllus are the potential source of α-amylase, lipase,
elastase, acetylcholinesterase, and butyrylcholinesterase inhibitors. Based on our finding, we concluded that the analyzed
plant species are of great scientific interest to the pharmaceutical, cosmetics, and food industry.